Literature DB >> 12916875

Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literature.

C Kobbervig1, D Norback, B Kahl.   

Abstract

Epstein-Barr virus (EBV) infection is nearly ubiquitous. While most primary EBV infections aremild and self-limited, occasional patients will develop severe complications of infectious mononucleosis (IM). Potentially fatal complications include fulminant hepatic failure, virus associated hemophagocytic syndrome and lymphoproliferative disorders. We report the case of an apparently immunocompetent 21-year-old woman with IM that progressed within weeks from a polyclonal B cell proliferation to a fatal B cell lymphoma.

Entities:  

Mesh:

Year:  2003        PMID: 12916875     DOI: 10.1080/1042819031000079221

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

1.  Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study.

Authors:  Pierre Tattevin; Yves Le Tulzo; Sophie Minjolle; Arnaud Person; Jean Marc Chapplain; Cedric Arvieux; Remi Thomas; Christian Michelet
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA.

Authors:  Guillermo Ruiz; Pilar Peña; Fernando de Ory; Juan Emilio Echevarría
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.

Authors:  Y N'guyen; L Andreoletti; M Patey; C Lecoq-Lafon; P Cornillet; A Léon; R Jaussaud; C Fieschi; C Strady
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

4.  Virological and immunological characteristics of fatal Epstein-Barr virus mononucleosis in a 17-year-old Caucasian male presenting with meningoencephalitis and hemophagocytic syndrome.

Authors:  Adriana Vince; Snjezana Zidovec Lepej; Ivan Kurelac; Bruno Barsic; Sanja Kozic; Igor Klinar; Kamelia Zarkovic
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.